{
    "doi": "https://doi.org/10.1182/blood.V106.11.2691.2691",
    "start_url": "https://ashpublications.org/blood/search-results?sort=Date+-+Oldest+First&f_ArticleTypeDisplayName=Meeting+Report&fl_SiteID=1000001&page=298",
    "start_url_page_num": 298,
    "is_scraped": "1",
    "article_title": "Incidence of Pulmonary Hypertension in Haemoglobinopathic Patients without Left Ventricular Disfunction. ",
    "article_date": "November 16, 2005",
    "session_type": "Poster Sessions",
    "abstract_text": "Incidence of Pulmonary Hypertension (PH) has been described in haemoglobinopathic patients, ranging from 10% to 50%, depending on age, therapy, coexisting left ventricular dysfunction (LVD) and classification of the disease. To determine whether PH can occurs in haemoglobinopathic patients in absence of overt LVD, we studied 1121 pts from 7 Thalassemia Centers in Italy(485 Thalassemia Major (TM), 458 thalassemia intermedia (TI), 178 Sickle Cell or Sickle Thalassemia Disease (SCD),49% males, mean age 30 yrs, range 13\u201356 yrs). In all pts echocardiographic (Echo) defined ejection fraction (EF%) was > 45% and clinically overt LVD was excluded. A cross-sectional Echo study was performed in order to detect PH that was prospectively defined as mild with tricuspid regurgitant jet velocity (TRV)of at least 2.5 m per second and defined as severe with a TRV> 3.5 m per second. Severe PH was observed in 9 pts, 3 with TM, in 6 with TI and in 1 patients with SCD. Mild PH occurs in 46 patients with TM, in 57 patients with TI and 11 pts with SCD. In the remaining patients, PH was in the normal range (TM 89,9%, TI 86,2% and SCD 93,2% of pts, respectively). In the whole group of hemoglobinopathic pts the incidence of PH (mild plus severe) range from 6.5 % to 13.8% of pts. PH (mild to severe) particularly affects pts with TI (13,8% of pts). Incidence of PH in TM, TI and SCD  Tricuspid Regurgitant Jet Velocity . Thal Major 485 pts . Thal Int 458 pts . SCD 178 pts . % pts . TRV<2.5 m/sec 436 (89.9%) 395 (86.2%) 166 (93.2%) 89% 2,5<TRV<3.5 m/sec 46 (9.4%) 57 (12.5%) 11 (6.2%) 10.1% TRV>3.5 m/sec 3 (0.6%) 6 (1.3%) 1 (0.9%) 0.9% Tricuspid Regurgitant Jet Velocity . Thal Major 485 pts . Thal Int 458 pts . SCD 178 pts . % pts . TRV<2.5 m/sec 436 (89.9%) 395 (86.2%) 166 (93.2%) 89% 2,5<TRV<3.5 m/sec 46 (9.4%) 57 (12.5%) 11 (6.2%) 10.1% TRV>3.5 m/sec 3 (0.6%) 6 (1.3%) 1 (0.9%) 0.9% View Large Our data support a significant presence of PH in haemoglobinopathic pts (6.2 to 13,8%) even though well treated and without LVD. Considering the pathophisiology of haemoglobinopathies a specific consideration to PH in these diseases is required in order to establish a preventive and therapeutic approach.",
    "topics": [
        "left ventricle",
        "pulmonary hypertension",
        "brachial plexus neuritis",
        "ventricular dysfunction, left",
        "echocardiography",
        "thalidomide",
        "cooley's anemia",
        "echo trial",
        "hemoglobin sickle thalassemia",
        "hemoglobinopathies"
    ],
    "author_names": [
        "Giorgio Derchi",
        "Francesco Formisano",
        "Martina Lamagna",
        "Renzo Galanello",
        "Patrizio Bina",
        "Maria Domenica Cappellini",
        "Maria Rosaria Fasulo",
        "Luciano Prossomariti",
        "Patrizia Cinque",
        "Aurelio Maggio",
        "Disma Renda",
        "Paolo Cianciulli",
        "Tiziana Cogliandro",
        "Antonio Piga",
        "Guido Donato",
        "Gian Luca Forni"
    ],
    "author_affiliations": [
        [
            "S.C.Cardiologia, Ospedali Galliera, Genova, Italy"
        ],
        [
            "S.C.Cardiologia, Ospedali Galliera, Genova, Italy"
        ],
        [
            "Centro della Microcitemia, Ospedali Galliera, Genova, Italy"
        ],
        [
            "Ospedale Regionale Microcitemico, Universita\u0300 di Cagliari, Cagliari, Italy"
        ],
        [
            "Ospedale Regionale Microcitemico, Universita\u0300 di Cagliari, Cagliari, Italy"
        ],
        [
            "Centro Anemie Congenite, Ospedale Policlinico IRCCS, Universita\u0300 di Milano, Milano, Italy"
        ],
        [
            "Centro Anemie Congenite, Ospedale Policlinico IRCCS, Universita\u0300 di Milano, Milano, Italy"
        ],
        [
            "Centro per le Microcitemie, Ospedale A Cardarelli, Napoli, Italy"
        ],
        [
            "Centro per le Microcitemie, Ospedale A Cardarelli, Napoli, Italy"
        ],
        [
            "Ematologia II con Talassemia, A.O. V. Cervello, Palermo, PA, Italy"
        ],
        [
            "Ematologia II con Talassemia, A.O. V. Cervello, Palermo, PA, Italy"
        ],
        [
            "U.O. Cardiologia and DH Talassemia, Ospedale S.Eugenio, Roma, Italy"
        ],
        [
            "U.O. Cardiologia and DH Talassemia, Ospedale S.Eugenio, Roma, Italy"
        ],
        [
            "Dipartimento di Scienze Pediatriche, Universita\u0300 di Torino, Torino, Italy"
        ],
        [
            "Dipartimento di Scienze Pediatriche, Universita\u0300 di Torino, Torino, Italy"
        ],
        [
            "Centro della Microcitemia, Ospedali Galliera, Genova, Italy"
        ]
    ],
    "first_author_latitude": "44.41269964999999",
    "first_author_longitude": "8.892294949999998"
}